Atalaya Capital Management’s Roivant Sciences Ltd. Warrant ROIVW Stock Holding History

Atalaya Capital Management’s Portfolio ROIVW Stock Details ROIVW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-150,200	Closed	-$372K	–	164
2023 Q2	$372K	Hold	150,200	–	–	0.18%	43
2023 Q1	$219K	Hold	150,200	–	–	0.07%	79
2022 Q4	$291K	Hold	150,200	–	–	0.05%	126
2022 Q3	$59K	Hold	150,200	–	–	0.01%	204
2022 Q2	$90K	Hold	150,200	–	–	0.01%	205
2022 Q1	$132K	Hold	150,200	–	–	0.01%	243
2021 Q4	$305K	Buy	+150,200	New	+$229K	0.03%	229

Atalaya Capital Management's ROIVW Position: Q3 2023 in Review

Atalaya Capital Management sold out of Roivant Sciences Ltd. Warrant (ROIVW) in Q3 2023, closing a stake of 150,200 shares — an estimated $372K sold.

Atalaya Capital Management first reported a position in ROIVW in Q4 2021 and held it in 7 quarters. The position peaked at $372K in Q2 2023. 0 funds tracked by Wall St. Rank hold ROIVW as of Q3 2023.

Atalaya Capital Management reported no remaining Roivant Sciences Ltd. Warrant position as of Q3 2023 after selling out during the quarter.
Atalaya Capital Management sold 150,200 Roivant Sciences Ltd. Warrant shares in Q3 2023, an estimated $372K.
Atalaya Capital Management first reported a position in Roivant Sciences Ltd. Warrant in Q4 2021 and held it in 7 quarters.
Atalaya Capital Management's Roivant Sciences Ltd. Warrant position peaked at $372K in Q2 2023.
0 funds tracked by Wall St. Rank held Roivant Sciences Ltd. Warrant as of Q3 2023.

Based on Atalaya Capital Management's 13F filing for Q3 2023, filed 6 Nov 2023.